Neurogenesis occurs in exclusive regions in the adult nervous system, the subventricular zone and dentate gyrus in the brain, and olfactory epithelium (OE) in the periphery. Cell replacement after death or injury, occurs to varying degrees in neural tissue, and is thought to be dependent upon the biological responses of stem and/or progenitor cells. Despite the progress made to identify adult OE and central nervous system (CNS) progenitors and lineage trace their progeny, our spatial and temporal understanding of embryonic OE neuroglial progenitors has been stalled by the paucity of identifiable genes able to distinguish individual candidate progenitors. In the developing CNS, radial glia serve as both neural progenitors and scaffolding for migrating neuroblasts and are identified by the expression of a select group of antigens, including nestin. Here, I show that the embryonic OE contains a novel radial glial-like progenitor (RGLP) that is not detected in adult OE. RGLPs express the radial glial antigens nestin, GLAST and RC2, but not brain lipid binding protein (BLBP), which, distinct from CNS radial glia, is instead found in olfactory ensheathing cells, a result confirmed using lineage tracing with BLBP-cre mice. Nestin-cre-mediated lineage tracing with three different reporters reveals that only a subpopulation of nestin-expressing RGLPs activate the “CNS-specific” nestin regulatory elements, and produce spatially restricted neurons in the OE and vomeronasal organ. The dorsal-medial restriction of transgene-activating cells is also seen in the embryonic OE of Nestin-GFP transgenic mice, where GFP is found in a subpopulation of GFP+ Mash1+ neuronal progenitors, despite the fact that endogenous nestin expression is found in RGLPs throughout the OE. In vitro, embryonic OE progenitors produce three biologically distinct colony subtypes, that when generated from Nestin-cre/ZEG mice, produce GFP+ neurons, recapitulating their in vivo phenotype, and are enriched for the most neurogenic colony subtype. Neurogenesis in vitro is driven by the proliferation of nestin+ progenitors in response to FGF2. I thus provide evidence for a novel neurogenic precursor, the RGLP of the OE, that can be regulated by FGF2, and provide the first evidence for intrinsic differences in the origin and spatiotemporal potential of distinct progenitors during OE development.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.

Diss. (sammanfattning) Uppsala : Univ., 2004. / Härtill 4 uppsatser.

Diss. (sammanfattning) Uppsala : Univ., 2001. / Härtill 5 uppsatser.

Diss. (sammanfattning) Uppsala : Uppsala universitet, 2006. / Härtill 5 uppsatser.

Thesis (Ph. D.)--University of Washington, 1998. / Vita. Includes bibliographical references (leaves [85]-99).

Thesis (M.Sc.)--Memorial University of Newfoundland, Faculty of Medicine, 1999. / Typescript. Bibliography: leaves 97-117.

Thesis (M.Sc.)--Memorial University of Newfoundland, 2003. / Bibliography: leaves 92-106. Also available online.

Orientador: Carlos Rossa Júnior / Banca: José Eduardo Cezar Sampaio / Banca: Ana Paula Vieira Colombo / Resumo: O objetivo do presente estudo foi avaliar in vitro o efeito do condicionamento radicular com fator de crescimento de fibroblastos básico (b-FGF) sobre a morfologia e densidade de fibroblastos. Para tal, blocos de dentina com 4 mm2 de área de superfície foram obtidos de raízes de dentes humanos extraídos devido severo envolvimento periodontal, sendo instrumentados manualmente e autoclavados. Noventa amostras foram selecionadas aleatoriamente e distribuídas em 3 grupos segundo o tratamento de superfície prévio ao condicionamento com o b-FGF: sem tratamento - controle; 50 mg/mL de cloridrato de tetraciclina e EDTA a 24%. As 30 amostras de cada um destes 3 grupos foram distribuídas em 3 subgrupos quanto à dose de b-FGF: 0 æg/mL - controle; 50 æg/mL e 125 æg/mL. Após os tratamentos, as amostras foram incubadas a 37º C e 98% de umidade com 2mL de meio Eagle, sendo 1mL com fibroblastos de linhagem contínua (células McCoy) na concentração de 1 x 105 células/mL e 1mL meio sem células, por 24 h. Após as 24 h, as amostras foram submetidas a preparo de rotina para MEV e então, fotomicrografadas nos aumentos de 500X (densidade celular) e 1000X (morfologia celular). Em seguida, as fotomicrografias foram avaliadas por 3 examinadores treinados, calibrados, independentes e cegos, os quais verificaram morfologia e densidade celular segundo os escores propostos por Gamal et al. (1998) e Jenkins et al. (1988), respectivamente. A aplicação da Análise de Regressão pela Técnica da Árvore demonstrou haver diferenças estatisticamente significantes para a densidade celular (p<0,0001) entre os grupos EDTA, tetraciclina e controle, sendo que também houve diferenças entre as doses de 0/50 æg e 125 æg de b-FGF nas amostras condicionadas com EDTA (p<0,0001) e entre as doses de 0 e 50/125 æg de b-FGF nas amostras condicionadas com tetraciclina... (Resumo completo, clicar acesso eletrônico abaixo). / Abstract: The aim of this study was to evaluate in vitro the effect of the root surface conditioning with basic fibroblast growth factor (b-FGF) about morphology and density of fibroblasts. Dentin slices of with 4 mm2 of surface area were obtained from roots of teeth extracted due to severe periodontal involvment. These were scaled and sterilized. Ninety samples were randomly distributed into 3 groups according to treatment before application of b-FGF: non-treated - control; 50mg/mL of tetracycline HCl and EDTA 24%. The thirty samples of each group were distributed into 3 subgroups according to the concentration of b-FGF: 0 æg/mL - control; 50 æg/mL and 125 æg/mL. After treatments, the samples were incubated at 37ºC and 98% humidity with 1mL of Eagle Medium with 1 x 105 cells/mL of fibroblast from continuos lineage (McCoy Cells) plus 1mL this solution without cells during 24 hours. The samples were submitted to routine preparation for SEM and photographed at 500x (density celular) and 1000x (morphology celular). Three independent and blind examiners evaluated the fibroblast's morphology and density, according to Gamam et al. (1998) and Jenkins et al. (1998), respectively. Classification and Regression Trees test results indicated significant differences on the density (p<0,0001) among EDTA, tetracycline and control groups with also differences between concentrations of 0/50æg and 125æg of b-FGF at the samples conditioning with EDTA (p<0,0001) and between concentrations of 0 and 50/125 æg of b-FGF at the samples conditioning with tetracycline(p<0,0001). The results of this test to morphology indicated significant differences between treatment or non-treatment with b-FGF, and that concentration of 125 æg demonstrated to be more favorable than the concentration of 50 æg. In conclusion, the treatment of root surfaces with b-FGF influenced the density... (Complete abstract, click electronic address below). / Mestre

Um dos grupos de doenças mais importante que acomete o desenvolvimento da caixa craniana humana é o das craniossinostoses, caracterizado pelo fechamento prematuro de uma ou mais suturas cranianas. Entre as formas mendelianas das craniossinostoses sindrômicas, mutações dominantes em FGFR2 são uma das causas mais frequentes e estão associadas às síndromes de Apert, de Crouzon e de Pfeiffer. A sinalização intracelular subseqüente à ativação de FGFR2, tanto selvagem quanto mutante, é bastante intrincada e pode sofrer inúmeras bifurcações. As porções iniciais destas vias, imediatamente subsequentes à ativação do receptor, são relativamente bem compreendidas. Grande parte, porém, do controle dessas vias, principalmente no que tange a regulação transcricional e sua associação com alterações em comportamentos celulares, não é entendido. Assim sendo, os objetivos gerais deste trabalho foram: 1) estudar o potencial de diferenciação e o perfil diferencial de transcrição gênica de culturas primárias de células fibroblastóides isoladas a partir do periósteo das suturas coronais de pacientes acometidos por síndrome de Apert (heterozigotos para a mutação de ganho de função p.Ser252Trp em FGFR2, a mutação mais comum em pacientes com esta síndrome) e 2) estudar o potencial de diferenciação osteogênico e o perfil transcricional respectivamente de células mesenquimais e de tecido provenientes de sutura coronal de um modelo murino para Síndromes de Crouzon/Pfeiffer (heterozigotos para a mutação p.Cys342Tyr em Fgfr2, a mutação mais comum associada a estas síndromes). Certificamo-nos da expressão gênica e proteica de FGFR2 nas células fibroblastóides humanas e de Fgfr2 nas células mesenquimais murinas. Em seguida, testamos o potencial osteogênico (in vitro e in vivo ) e adipogênico (in vitro ) das células de pacientes com Síndrome de Apert, comparadas a células do mesmo tecido mas de indivíduos sem esta mutação e o potencial osteogênico (in vitro ) das células mesenquimais de camundongos portadores da mutação p.Cys342Tyr em Fgfr2, comparadas a células também das suturas coronais mas de animais selvagens. O potencial de diferenciação das células mutantes, nos dois grupos de experimentos, foi muito aumentado em relação ao potencial das células livres destas mutações. Conduzimos experimentos de microarrays de expressão gênica (sistema CodeLink) com 7 amostras de culturas primárias de células de pacientes com S. de Apert e as comparamos com 7 amostras de culturas primárias controles. Identificamos 263 genes com valores de expressão estatisticamente diferentes (SNR &#8805; |0.4|, P &#8804; 0,05) nas amostras de pacientes com S. de Apert quando comparadas às controles (118 superexpressos, 145 subexpressos). Categorias funcionais enriquecidas foram regulação de proliferação celular, metabolismo de nucleotídeos, regulação de expressão gênica, adesão celular, organização de matriz extracelular e cascata PI3K MAPK. Para a validação deste experimento constatamos superexpressão, por PCR em tempo real, de genes identificados como superexpressos na assinatura de expressão associada às células mutadas, além de verificarmos o mesmo comportamento destes genes em células controles tratadas com FGF2 exógeno para superativação do receptor. Os experimentos de expressão gênica com os tecidos de suturas coronais do modelo murino foram feitos com 15 amostras de tecidos de animais mutantes em 3 grupos de 5 e comparadas a amostras de mesmo tecido de animais selvagens agrupadas da mesma forma. Identificamos três listas de genes diferencialmente expressos: a primeira contendo 188 transcritos (P &#8804;0,05, FC &#8805; 1,5,sendo 91 superexpressos e 97 subexpressos), e as outras duas filtradas previamente para coeficiente de variação &lt; 50% dentro de cada grupo, contendo 488 transcritos (P &#8804;0,05, FC &#8805; 1,2, sendo 183 superexpressos e 305 subexpressos) e 31 transcritos (P &#8804;0,05, FC &#8805; 1,5, sendo 11 superexpressos e 20 subexpressos). Categorias funcionais mais enriquecidas foram crescimento, proliferação e ciclo celular, diferenciação celular, sinalização célula-célula, resposta imune mediada por células e sinalização por receptor Wnt. Estes resultados nos permitiram: a) demonstrar que células fibroblastóides de periósteo craniano de paciente portadores de S. de Apert (mutação p.Ser252Trp em FGFR2) e células mesenquimais do modelo murino para S. de Crouzon e Pfeiffer, portador da mutação p.Cys342Tyr em Fgfr2, apresentam potencial osteogênico aumentado, agregando evidências que sugerem que esta alteração de comportamento celular tem função fundamental no desencadeamento das craniossinostoses nestas síndromes; b) revelar assinaturas de expressão gênicas associadas a estas mutações nas condições estudadas, que podem reger este comportamento celular anormal; c) identificar um novo grupo de genes associados à patofisiologia da Síndrome de Apert ou às características fenotípicas do modelo murino investigado, podendo também ser genes candidatos a outras craniossinostoses de causa desconhecida. / Craniosynostosis is one of the most important group of diseases linked to the development of the human skull and is characterized by the premature fusion of one or more cranial sutures. Dominant mutations in FGFR2 are frequent molecular causes amongst the mendelian inherited forms of the syndromic craniosynostosis and are associated to Apert, Crouzon and Pfeiffer syndromes. The intracellular signaling pathways following the activation of wild type or mutant FGFR2 are very complex due to several possible bifurcations. The initial portions of these pathways, immediately following the receptor activation, are relatively well delineated. However the great majority of the events related to the control of these pathways is still not well understood, mainly concerning its transcriptional regulation and its association to other cell behavior anomalies. Therefore the key scopes of this work were: 1) to study the differentiation potential and the differential gene expression profile of primary fibroblastoid cell cultures isolated from the periosteum of the coronal sutures of Apert Syndrome patients (heterozygous for the mutation p.Ser252Trp in FGFR2, the most common cause of the Apert Syndrome condition) and 2) to study the osteogenic differentiation potential and the transcriptional profile of mesenchymal cells and tissue isolated from the coronal sutures of a mouse model for the Crouzon and Pfeiffer Syndromes (heterozygous for the p.Cys342Tyr mutation in Fgfr2, the mutation most commonly associated to these syndromes). We assured the FGFR2 /FGFR2 gene and the protein expression in human fibroblastoid cells and Fgfr2 /Fgfr2 expression in the mesenchymal murine cells. We tested the (in vitro and in vivo ) osteogenic and the (in vitro ) adipogenic potentials of the Apert Syndrome patients cells compared to cells from the same tissue but from subjects without this mutation and the (in vitro ) osteogenic potential of mesenchymal cells from mice bearing the p.Cys342Tyr mutation in Fgfr2 compared to coronal suture cells but from wild type mice. On both experiments the differentiation potential of the mutant cells were very increased when compared to the potential of the wild type cells. We conducted gene expression microarray experiments (CodeLink system) using 7 samples from primary cultures of cells from Apert Syndrome patients compared to 7 samples from primary control cultures. We identified 263 genes with significantly different expression (SNR &#8805; |0.4|, P &#8804; 0,05) associated to the Apert Syndrome profile (118 upregulated, 145 downregulated). Enriched functional cathegories were regulation of cell proliferation, nucleotide metabolism, gene expression regulation, cell adhesion, extracellular matrix organization and PI3K MAPK cascades. In order to validate this gene expression signature we confirmed through Real-Time PCR the upregulation of genes identified as upregulated in the Apert cell profile in samples from the microarray experiment and in control cells treated with exogenous overactivate the receptor. The gene expression experiments with the coronal suture tissues from the mouse model were performed with 15 samples of mutant animal tissue in 3 groups of 5 and compared to samples from the same tissue of wild type animals, with identical grouping. We identified three sets of differentially expressed genes: the first set containing 188 transcripts (P &#8804;0,05, FC &#8805; 1,5, 91 upregulated e 97 downregulated), and the other two filtered for coeficient of variation &lt; 50% in each group, containing 488 transcripts (P &#8804;0,05, FC &#8805; 1,2, sendo 183 upregulated and 305downregulated) e 31 transcripts (P &#8804;0,05, FC &#8805; 1,5, 11 upregulated and 20 downregulated). The most enriched functional categories were growth, proliferation and cell cycle, cell differentiation, cell-to-cell signaling, cell mediated immune response and Wnt receptor signaling. These results allowed us: a) to demonstrate that fibroblastoid cells from coronal periosteum PF Apert Syndrome patients (p.Ser252Trp mutation in FGFR2) and mesenchymal cells from the coronal tissue of the mouse model for Crouzon and Pfeiffer syndromes (bearing the p.Cys342Tyr in Fgfr2) have enhanced osteogenic potential, summoning evidences suggesting that this cell behavior alteration have a fundamental role to the craniosynostotic process in these syndromes; b) to unravel gene expression signatures linked to these mutations in the studied conditions, that could orchestrate this abnormal cell behavior; c) to identify a ser of genes associated to the pathophysiology of Apert Syndrome and to the phenotypic characteristics of the animal model investigated, which might be candidate genes to other craniosynostosis of unknown cause.